Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jul 4;17(1):123.
doi: 10.1186/s12916-019-1357-y.

Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbers

Jörn M Schattenberg  1 , Mattias Ekstedt  2
Affiliations
Comment

Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbers

Jörn M Schattenberg et al. BMC Med. .
No abstract available

Keywords: Advanced fibrosis; Awareness; Epidemiology; Fib-4; Hepatocellular carcinoma; NAFLD; NASH; Real-world data; Screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Comment on

References

    1. Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904. doi: 10.1016/j.jhep.2018.05.036. - DOI - PubMed
    1. Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70(3):531–544. doi: 10.1016/j.jhep.2018.10.033. - DOI - PubMed
    1. Hagstrom H, Nasr P, Ekstedt M, Hammar U, Stål P, Hultcrantz R, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67(6):1265–1273. doi: 10.1016/j.jhep.2017.07.027. - DOI - PubMed
    1. Huber Y, Boyle M, Hallsworth K, Tiniakos D, Straub BK, Labenz C, et al. Health-related quality of life in non-alcoholic fatty liver disease associates with hepatic inflammation. Clin Gastroenterol Hepatol. 2018:S1542-3565(18)31392–31392. - PubMed
    1. Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, et al. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. BMC Med. 2019;17:95. doi: 10.1186/s12916-019-1321-x. - DOI - PMC - PubMed